Esti Hayun
Keine laufenden Positionen mehr
Profil
Esti Hayun worked as a Finance Manager at ColBar LifeScience Ltd.
She then worked as a Chief Financial Officer at Geffen Residence & Renewal Ltd.
and Proteologics, Inc. She also worked as a Finance Manager at Colbar R&D Ltd.
and as a Chief Financial Officer at Atox Bio Ltd.
Hayun holds a graduate degree from Bar-Ilan University and an undergraduate degree from The College of Management Academic Studies.
Ehemalige bekannte Positionen von Esti Hayun
| Unternehmen | Position | Ende |
|---|---|---|
| GEFFEN RESIDENCE & RENEWAL LTD | Finanzdirektor/CFO | 01.01.2010 |
| Proteologics, Inc. | Finanzdirektor/CFO | 01.01.2010 |
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Finanzdirektor/CFO | - |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Finanzdirektor/CFO | - |
| Colbar R&D Ltd. | Finanzdirektor/CFO | - |
Ausbildung von Esti Hayun
| Bar-Ilan University | Graduate Degree |
| The College of Management Academic Studies | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GEFFEN RESIDENCE & RENEWAL LTD | Process Industries |
| Private Unternehmen | 4 |
|---|---|
| Colbar R&D Ltd. | |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
ColBar LifeScience Ltd.
ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Health Technology |
| Proteologics, Inc. |
